Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG) and The Ensign Group (ENSG)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MiMedx Group (MDXG – Research Report) and The Ensign Group (ENSG – Research Report) with bullish sentiments.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MiMedx Group (MDXG)
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on MiMedx Group today. The company’s shares closed last Friday at $6.76.
According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of
MiMedx Group has an analyst consensus of Strong Buy, with a price target consensus of $12.00, implying an 84.3% upside from current levels. In a report issued on November 13, TR | OpenAI – 4o also upgraded the stock to Buy with a $8.50 price target.
See the top stocks recommended by analysts >>
The Ensign Group (ENSG)
In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on The Ensign Group, with a price target of $210.00. The company’s shares closed last Friday at $184.99.
According to TipRanks.com, Wiederhorn is a 5-star analyst with an average return of
The Ensign Group has an analyst consensus of Strong Buy, with a price target consensus of $209.00, which is a 16.4% upside from current levels. In a report issued on November 13, RBC Capital also reiterated a Buy rating on the stock with a $206.00 price target.
Read More on MDXG:
